| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Trauma Surgery, Hamburg University School of Medicine (M.A., M.P., T.H., J.M.R.), Hamburg, Germany; the Department of Cell Biology, Yale University School of Medicine (M.A., R.B.), New Haven, Connecticut 06510; and the Endocrine Unit, Massachusetts General Hospital, Harvard Medical School (K.C., M.B.D.), Boston, Massachusetts 02114
Address all correspondence and requests for reprints to: Dr. Marie Demay, Endocrine Unit, Wellman 501, Massachusetts General Hospital, Boston, Massachusetts 02114. E-mail: demay{at}helix.mgh.harvard.edu
1,25-Dihydroxyvitamin D3 has been shown to play an important role in vitro in regulating osteoblast gene transcription and promoting osteoclast differentiation. To address the role of the vitamin D receptor (VDR) in skeletal homeostasis, formal histomorphometric analyses were performed in VDR null mice in the setting of impaired mineral ion homeostasis as well as in VDR null mice in whom normal mineral ion homeostasis had been preserved. In hypocalcemic VDR null mice, there was an increase in bone volume as a result of a dramatic increase in osteoid. There was also an increase in the number of osteoblasts without a significant change in the number of osteoclasts. Examination of the growth plate revealed marked disorganization, with an increase in vascularity and matrix. Biomechanical parameters demonstrated increased bone fragility in the hypocalcemic VDR null mice.
In the VDR ablated mice in whom normal mineral ion homeostasis had been preserved, none of these measurements was significantly different from those in wild-type littermates raised under identical conditions. Notably, the morphology and width of the growth plate were indistinguishable from those in wild-type controls, demonstrating that a calcium/phosphorus/lactose-enriched diet started at 16 days of age in the VDR null mice permits the development of both normal morphology in the growth cartilage and adjacent metaphysis and normal biomechanical competence of cortical bone. Thus, the principle action of the VDR in skeletal growth, maturation, and remodeling is its role in intestinal calcium absorption. The skeletal consequences of VDR ablation are a result of impaired intestinal calcium absorption and/or the resultant secondary hyperparathyroidism and hypophosphatemia.
This article has been cited by other articles:
![]() |
R. Samadfam, C. Richard, L. Nguyen-Yamamoto, I. Bolivar, and D. Goltzman Bone Formation Regulates Circulating Concentrations of Fibroblast Growth Factor 23 Endocrinology, November 1, 2009; 150(11): 4835 - 4845. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meir, R. Levi, L. Lieben, S. Libutti, G. Carmeliet, R. Bouillon, J. Silver, and T. Naveh-Many Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1192 - F1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, J. Zhou, W. Tang, R. Menard, J. Q. Feng, and L. D. Quarles Pathogenic role of Fgf23 in Dmp1-null mice Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E254 - E261. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Benn, D. Ajibade, A. Porta, P. Dhawan, M. Hediger, J.-B. Peng, Y. Jiang, G. T. Oh, E.-B. Jeung, L. Lieben, et al. Active Intestinal Calcium Transport in the Absence of Transient Receptor Potential Vanilloid Type 6 and Calbindin-D9k Endocrinology, June 1, 2008; 149(6): 3196 - 3205. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chaudhuri Nuclear Receptors and Female Reproduction: A Tale of 3 Scientists, Jensen, Gustafsson, and O'Malley Reproductive Sciences, February 1, 2008; 15(2): 110 - 120. [Abstract] [PDF] |
||||
![]() |
C. Galli, L. A. Zella, J. A. Fretz, Q. Fu, J. W. Pike, R. S. Weinstein, S. C. Manolagas, and C. A. O'Brien Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Reduces Bone Remodeling and Increases Bone Mass Endocrinology, January 1, 2008; 149(1): 146 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rowling, C. Gliniak, J. Welsh, and J. C. Fleet High Dietary Vitamin D Prevents Hypocalcemia and Osteomalacia in CYP27B1 Knockout Mice J. Nutr., December 1, 2007; 137(12): 2608 - 2615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Demay, Y. Sabbagh, and T. O. Carpenter Calcium and Vitamin D: What Is Known About the Effects on Growing Bone Pediatrics, March 1, 2007; 119(Supplement_2): S141 - S144. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Moore, S. Kato, W. Xie, D. J. Mangelsdorf, D. R. Schmidt, R. Xiao, and S. A. Kliewer International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor Pharmacol. Rev., December 1, 2006; 58(4): 742 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Felsenfeld and B. S. Levine Milk Alkali Syndrome and the Dynamics of Calcium Homeostasis Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 641 - 654. [Full Text] [PDF] |
||||
![]() |
L. Rodriguez, C. Tu, Z. Cheng, T.-H. Chen, D. Bikle, D. Shoback, and W. Chang Expression and Functional Assessment of an Alternatively Spliced Extracellular Ca2+-Sensing Receptor in Growth Plate Chondrocytes Endocrinology, December 1, 2005; 146(12): 5294 - 5303. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. J. van der Eerden, J. G. J. Hoenderop, T. J. de Vries, T. Schoenmaker, C. J. Buurman, A. G. Uitterlinden, H. A. P. Pols, R. J. M. Bindels, and J. P. T. M. van Leeuwen The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption PNAS, November 29, 2005; 102(48): 17507 - 17512. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rodriguez, Z. Cheng, T.-H. Chen, C. Tu, and W. Chang Extracellular Calcium and Parathyroid Hormone-Related Peptide Signaling Modulate the Pace of Growth Plate Chondrocyte Differentiation Endocrinology, November 1, 2005; 146(11): 4597 - 4608. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kallay, G. Bises, E. Bajna, C. Bieglmayer, W. Gerdenitsch, I. Steffan, S. Kato, H.J. Armbrecht, and H. S. Cross Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention Carcinogenesis, September 1, 2005; 26(9): 1581 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bundschu, K.-P. Knobeloch, M. Ullrich, T. Schinke, M. Amling, C. M. Engelhardt, T. Renne, U. Walter, and K. Schuh Gene Disruption of Spred-2 Causes Dwarfism J. Biol. Chem., August 5, 2005; 280(31): 28572 - 28580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sabbagh, T. O. Carpenter, and M. B. Demay Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes PNAS, July 5, 2005; 102(27): 9637 - 9642. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kovacs, M. L. Woodland, N. J. Fudge, and J. K. Friel The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E133 - E144. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schmidt, T. Schinke, M. Haberland, M. Priemel, A. F. Schilling, C. Mueldner, J. M. Rueger, E. Sock, M. Wegner, and M. Amling The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation J. Cell Biol., March 14, 2005; 168(6): 899 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mizobuchi, I. Hatamura, H. Ogata, F. Saji, S. Uda, K. Shiizaki, T. Sakaguchi, S. Negi, E. Kinugasa, S. Koshikawa, et al. Calcimimetic Compound Upregulates Decreased Calcium-Sensing Receptor Expression Level in Parathyroid Glands of Rats with Chronic Renal Insufficiency J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2579 - 2587. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Larsson, R. Marsell, E. Schipani, C. Ohlsson, O. Ljunggren, H. S. Tenenhouse, H. Juppner, and K. B. Jonsson Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the {alpha}1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate Homeostasis Endocrinology, July 1, 2004; 145(7): 3087 - 3094. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Panda, D. Miao, I. Bolivar, J. Li, R. Huo, G. N. Hendy, and D. Goltzman Inactivation of the 25-Hydroxyvitamin D 1{alpha}-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis J. Biol. Chem., April 16, 2004; 279(16): 16754 - 16766. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kenner, A. Hoebertz, T. Beil, N. Keon, F. Karreth, R. Eferl, H. Scheuch, A. Szremska, M. Amling, M. Schorpp-Kistner, et al. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects J. Cell Biol., February 16, 2004; 164(4): 613 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Zanello and A. W. Norman Rapid modulation of osteoblast ion channel responses by 1{alpha},25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor PNAS, February 10, 2004; 101(6): 1589 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Demay Muscle: A Nontraditional 1,25-Dihydroxyvitamin D Target Tissue Exhibiting Classic Hormone-Dependent Vitamin D Receptor Actions Endocrinology, December 1, 2003; 144(12): 5135 - 5137. [Full Text] [PDF] |
||||
![]() |
M. Froicu, V. Weaver, T. A. Wynn, M. A. McDowell, J. E. Welsh, and M. T. Cantorna A Crucial Role for the Vitamin D Receptor in Experimental Inflammatory Bowel Diseases Mol. Endocrinol., December 1, 2003; 17(12): 2386 - 2392. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. M. Sutton and P. N. MacDonald Vitamin D: More Than a "Bone-a-Fide" Hormone Mol. Endocrinol., May 1, 2003; 17(5): 777 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Ballock and R. J. O'Keefe The Biology of the Growth Plate J. Bone Joint Surg. Am., March 31, 2003; 85(4): 715 - 726. [Full Text] [PDF] |
||||
![]() |
W. G. Goodman Medical management of secondary hyperparathyroidism in chronic renal failure Nephrol. Dial. Transplant., March 1, 2003; 18(90003): iii2 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chang, C. Tu, S. Pratt, T.-H. Chen, and D. Shoback Extracellular Ca2+-Sensing Receptors Modulate Matrix Production and Mineralization in Chondrogenic RCJ3.1C5.18 Cells Endocrinology, April 1, 2002; 143(4): 1467 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yagishita, Y. Yamamoto, T. Yoshizawa, K. Sekine, Y. Uematsu, H. Murayama, Y. Nagai, W. Krezel, P. Chambon, T. Matsumoto, et al. Aberrant Growth Plate Development in VDR/RXR{gamma} Double Null Mutant Mice Endocrinology, December 1, 2001; 142(12): 5332 - 5341. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Van Cromphaut, M. Dewerchin, J. G. J. Hoenderop, I. Stockmans, E. Van Herck, S. Kato, R. J. M. Bindels, D. Collen, P. Carmeliet, R. Bouillon, et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects PNAS, October 25, 2001; (2001) 231474698. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Li, M. J. G. Bolt, L.-P. Cao, and M. D. Sitrin Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E558 - E564. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Panda, D. Miao, M. L. Tremblay, J. Sirois, R. Farookhi, G. N. Hendy, and D. Goltzman Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction PNAS, June 19, 2001; 98(13): 7498 - 7503. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Gonzalez The role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy Nephrol. Dial. Transplant., July 1, 2000; 15(7): 945 - 950. [Full Text] [PDF] |
||||
![]() |
R. St-Arnaud, A. Arabian, R. Travers, F. Barletta, M. Raval-Pandya, K. Chapin, J. Depovere, C. Mathieu, S. Christakos, M. B. Demay, et al. Deficient Mineralization of Intramembranous Bone in Vitamin D-24-Hydroxylase-Ablated Mice Is Due to Elevated 1,25-Dihydroxyvitamin D and Not to the Absence of 24,25-Dihydroxyvitamin D Endocrinology, July 1, 2000; 141(7): 2658 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Van Cromphaut, M. Dewerchin, J. G. J. Hoenderop, I. Stockmans, E. Van Herck, S. Kato, R. J. M. Bindels, D. Collen, P. Carmeliet, R. Bouillon, et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects PNAS, November 6, 2001; 98(23): 13324 - 13329. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |